Amedisys (NASDAQ:AMED) quickly dropped 4% after a report that the Dept. of Justice is leaning toward filing a lawsuit to ...

Amedisys, for the third quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, ...

Amedisys is being acquired by UnitedHealth for $3.3B, pending DOJ approval. Learn why UNH and AMED stock are impacted by ...

Amedisys Inc ( (AMED) ) has released its Q3 earnings. Here is a breakdown of the information Amedisys Inc presented to its investors. Amedisys, ...

Home health company Amedisys, based in Louisiana and Nashville, fell short of estimates in its third quarter earnings report.

UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers ...

Donald Trump will take over the presidency again in January. There will be many implications for home-based care providers, ...

For the quarter ended September 2024, Amedisys (AMED) reported revenue of $587.67 million, up 5.7% over the same period last year. EPS came in at $1.00, compared to $0.98 in the year-ago quarter.

Amedisys shares have risen roughly 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $97.71, a rise of nearly 6% in the last 12 months.

BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Net service ...

The results fell short of Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $1.14 per share.